Symbols / SRRK $47.33 -1.60% Scholar Rock Holding Corporation

Healthcare • Biotechnology • United States • NMS
SRRK Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 5.44B Enterprise Value 5.18B Income -377.94M Sales — Book/sh 2.26 Cash/sh 3.20
Dividend Yield — Payout 0.00% Employees 289 IPO — P/E — Forward P/E -22.02
PEG — P/S — P/B 20.91 P/C — EV/EBITDA -13.52 EV/Sales —
Quick Ratio 6.68 Current Ratio 6.95 Debt/Eq 44.37 LT Debt/Eq — EPS (ttm) — EPS next Y -2.15
EPS Growth — Revenue Growth — Earnings 2026-05-07 ROA -54.69% ROE -123.08% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand — Shs Float 95.61M Short Float 21.37%
Short Ratio 8.76 Short Interest — 52W High 51.62 52W Low 27.07 Beta 0.69 Avg Volume 1.40M
Volume 970.96K Target Price $57.73 Recom Strong_buy Prev Close $48.10 Price $47.33 Change -1.60%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$57.73
Proxy: analyst mean price target (no FCF/EPS data available).
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest SRRK news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-16 VAISHNAW AKSHAY K Officer and Director — 12,246 $49.57 $607,089
2026-04-16 WOODS KEITH Chief Operating Officer — 10,220 $49.57 $506,651
2026-04-16 SINHA VIKAS Chief Financial Officer — 10,410 $49.57 $516,071
2026-04-16 HALLAL DAVID L Chief Executive Officer — 30,615 $49.57 $1,517,723
2026-02-23 QATANANI MOHAMMED Officer — 8,484 $46.94 $399,351
2026-02-17 MARANTZ JING L. Officer — 4,157 $46.53 $193,418
2026-02-17 HO JUNLIN General Counsel — 9,580 $46.53 $445,740
2026-02-17 PARLAVECCHIO CARYN Officer — 9,035 $46.53 $420,382
2026-02-17 QATANANI MOHAMMED Officer — 7,989 $46.53 $371,714
2026-02-09 VAISHNAW AKSHAY K Officer and Director — 47,021 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
-100.00%
33.19
Operating Revenue
0.00
0.00
0.00
-100.00%
33.19
Operating Expense
384.64
+52.60%
252.05
+47.15%
171.29
+2.23%
167.56
Research And Development
208.44
+12.95%
184.55
+51.39%
121.90
-2.04%
124.44
Selling General And Administration
176.21
+161.03%
67.50
+36.66%
49.40
+14.56%
43.12
General And Administrative Expense
176.21
+161.03%
67.50
+36.66%
49.40
+14.56%
43.12
Other Gand A
176.21
+161.03%
67.50
+36.66%
49.40
+14.56%
43.12
Total Expenses
384.64
+52.60%
252.05
+47.15%
171.29
+2.23%
167.56
Operating Income
-384.64
-52.60%
-252.05
-47.15%
-171.29
-27.48%
-134.37
Total Operating Income As Reported
-384.64
-52.60%
-252.05
-47.15%
-171.29
-27.48%
-134.37
EBITDA
-369.39
-55.52%
-237.52
-41.00%
-168.45
-28.21%
-131.38
Normalized EBITDA
-369.39
-55.52%
-237.52
-41.00%
-168.45
-28.21%
-131.38
Reconciled Depreciation
1.66
-14.40%
1.94
-31.89%
2.84
-4.76%
2.99
EBIT
-371.05
-54.95%
-239.46
-39.79%
-171.29
-27.48%
-134.37
Net Income
-377.94
-53.45%
-246.29
-48.56%
-165.79
-23.26%
-134.50
Pretax Income
-377.94
-53.45%
-246.29
-48.56%
-165.79
-23.26%
-134.50
Net Non Operating Interest Income Expense
7.01
+19.88%
5.84
—
—
Interest Expense Non Operating
6.89
+0.82%
6.84
—
—
Net Interest Income
7.01
+19.88%
5.84
—
—
Interest Expense
6.89
+0.82%
6.84
—
—
Interest Income Non Operating
13.90
+9.60%
12.68
—
—
Interest Income
13.90
+9.60%
12.68
—
—
Other Income Expense
-0.30
-254.12%
-0.09
-101.54%
5.51
+4271.21%
-0.13
Other Non Operating Income Expenses
-0.30
-254.12%
-0.09
-101.54%
5.51
+4271.21%
-0.13
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-377.94
-53.45%
-246.29
-48.56%
-165.79
-23.26%
-134.50
Net Income From Continuing Operation Net Minority Interest
-377.94
-53.45%
-246.29
-48.56%
-165.79
-23.26%
-134.50
Net Income From Continuing And Discontinued Operation
-377.94
-53.45%
-246.29
-48.56%
-165.79
-23.26%
-134.50
Net Income Continuous Operations
-377.94
-53.45%
-246.29
-48.56%
-165.79
-23.26%
-134.50
Normalized Income
-377.94
-53.45%
-246.29
-48.56%
-165.79
-23.26%
-134.50
Net Income Common Stockholders
-377.94
-53.45%
-246.29
-48.56%
-165.79
-23.26%
-134.50
Diluted EPS
-3.29
-33.20%
-2.47
-24.12%
-1.99
+11.95%
-2.26
Basic EPS
-3.29
-33.20%
-2.47
-24.12%
-1.99
+11.95%
-2.26
Basic Average Shares
114.70
+14.89%
99.84
+19.79%
83.35
+39.82%
59.61
Diluted Average Shares
114.70
+14.89%
99.84
+19.79%
83.35
+39.82%
59.61
Diluted NI Availto Com Stockholders
-377.94
-53.45%
-246.29
-48.56%
-165.79
-23.26%
-134.50
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
404.27
-14.88%
474.92
+52.69%
311.04
-13.16%
358.17
Current Assets
385.15
-14.63%
451.17
+56.55%
288.19
-12.14%
328.02
Cash Cash Equivalents And Short Term Investments
367.56
-15.94%
437.28
+56.21%
279.94
-11.23%
315.36
Cash And Cash Equivalents
323.53
+81.88%
177.88
+74.64%
101.86
-1.37%
103.28
Other Short Term Investments
44.04
-83.02%
259.40
+45.66%
178.08
-16.03%
212.09
Receivables
2.80
+30.13%
2.15
+99.91%
1.08
-60.66%
2.73
Other Receivables
2.80
+30.13%
2.15
+99.91%
1.08
-60.66%
2.73
Prepaid Assets
14.79
+25.98%
11.74
+63.45%
7.18
-27.68%
9.93
Other Current Assets
—
—
—
12.66
Total Non Current Assets
19.12
-19.50%
23.76
+4.01%
22.84
-24.23%
30.14
Net PPE
12.09
-34.33%
18.41
+14.91%
16.02
-38.22%
25.93
Gross PPE
26.96
-14.74%
31.62
+15.65%
27.34
-24.38%
36.16
Accumulated Depreciation
-14.88
-12.54%
-13.22
-16.70%
-11.33
-10.70%
-10.23
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
2.27
+10.38%
2.06
-0.67%
2.08
-3.80%
2.16
Construction In Progress
0.03
0.00
—
0.00
Other Properties
21.04
-18.93%
25.95
+19.65%
21.69
-24.80%
28.84
Leases
3.63
+0.36%
3.61
+0.89%
3.58
-30.60%
5.16
Goodwill And Other Intangible Assets
—
2.40
-41.21%
4.07
—
Other Intangible Assets
—
2.40
-41.21%
4.07
—
Non Current Prepaid Assets
3.23
+9.71%
2.94
-33.33%
4.42
—
Other Non Current Assets
3.81
+58.16%
2.41
+0.00%
2.41
-42.92%
4.22
Total Liabilities Net Minority Interest
158.78
+49.39%
106.29
+23.85%
85.82
-12.37%
97.93
Current Liabilities
55.42
+18.07%
46.94
+43.36%
32.74
-10.03%
36.39
Payables And Accrued Expenses
49.87
+21.15%
41.16
+72.13%
23.91
-15.54%
28.32
Payables
10.30
+2.06%
10.10
+191.34%
3.46
-13.24%
3.99
Accounts Payable
10.30
+2.06%
10.10
+191.34%
3.46
-13.24%
3.99
Other Payable
—
—
—
—
Current Accrued Expenses
39.57
+27.36%
31.07
+51.92%
20.45
-15.92%
24.32
Current Debt And Capital Lease Obligation
5.55
-3.88%
5.77
-33.95%
8.74
+11.33%
7.85
Current Debt
—
—
1.33
—
Other Current Borrowings
—
—
1.33
—
Current Capital Lease Obligation
5.55
-3.88%
5.77
-22.06%
7.41
-5.65%
7.85
Current Deferred Liabilities
—
—
—
0.00
Current Deferred Revenue
—
—
—
0.00
Other Current Liabilities
—
—
0.09
-61.71%
0.22
Total Non Current Liabilities Net Minority Interest
103.36
+74.16%
59.35
+11.82%
53.08
-13.76%
61.54
Long Term Debt And Capital Lease Obligation
103.36
+74.16%
59.35
+11.82%
53.08
-13.76%
61.54
Long Term Debt
99.71
+98.84%
50.15
+3.00%
48.68
-2.13%
49.74
Long Term Capital Lease Obligation
3.66
-60.29%
9.21
+109.61%
4.39
-62.78%
11.80
Stockholders Equity
245.49
-33.41%
368.63
+63.68%
225.22
-13.46%
260.24
Common Stock Equity
245.49
-33.41%
368.63
+63.68%
225.22
-13.46%
260.24
Capital Stock
0.11
+14.89%
0.09
+23.68%
0.08
+46.15%
0.05
Common Stock
0.11
+14.89%
0.09
+23.68%
0.08
+46.15%
0.05
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
108.46
+15.60%
93.82
+23.49%
75.98
+47.04%
51.67
Ordinary Shares Number
108.46
+15.60%
93.82
+23.49%
75.98
+47.04%
51.67
Additional Paid In Capital
1,545.94
+19.74%
1,291.10
+43.22%
901.47
+16.82%
771.70
Retained Earnings
-1,300.65
-40.96%
-922.72
-36.41%
-676.42
-32.47%
-510.63
Gains Losses Not Affecting Retained Earnings
0.09
-41.25%
0.16
+73.91%
0.09
+110.41%
-0.88
Other Equity Adjustments
0.09
-41.25%
0.16
+73.91%
0.09
+110.41%
-0.88
Total Equity Gross Minority Interest
245.49
-33.41%
368.63
+63.68%
225.22
-13.46%
260.24
Total Capitalization
345.20
-17.57%
418.78
+52.89%
273.90
-11.64%
309.98
Working Capital
329.73
-18.43%
404.23
+58.24%
255.45
-12.41%
291.63
Invested Capital
345.20
-17.57%
418.78
+52.15%
275.24
-11.21%
309.98
Total Debt
108.92
+67.24%
65.13
+5.35%
61.82
-10.92%
69.40
Capital Lease Obligations
9.21
-38.54%
14.98
+26.95%
11.80
-39.96%
19.65
Net Tangible Assets
245.49
-33.41%
368.63
+63.68%
225.22
-13.46%
260.24
Tangible Book Value
245.49
-33.41%
368.63
+63.68%
225.22
-13.46%
260.24
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-300.04
-49.31%
-200.95
-38.37%
-145.23
-9.44%
-132.69
Cash Flow From Continuing Operating Activities
-300.04
-49.31%
-200.95
-38.37%
-145.23
-9.44%
-132.69
Net Income From Continuing Operations
-377.94
-53.45%
-246.29
-48.56%
-165.79
-23.26%
-134.50
Depreciation Amortization Depletion
1.66
-14.40%
1.94
-31.89%
2.84
-4.76%
2.99
Depreciation And Amortization
1.66
-14.40%
1.94
-31.89%
2.84
-4.76%
2.99
Other Non Cash Items
5.68
+3.80%
5.48
-25.99%
7.40
-2.87%
7.62
Stock Based Compensation
75.60
+106.40%
36.63
+34.95%
27.14
-2.02%
27.70
Operating Gains Losses
—
—
0.01
-66.67%
0.03
Gain Loss On Sale Of PPE
—
0.00
-100.00%
0.01
-66.67%
0.03
Change In Working Capital
-1.05
-115.92%
6.59
+162.13%
-10.61
+69.14%
-34.39
Change In Receivables
—
—
—
—
Changes In Account Receivables
—
—
—
—
Change In Prepaid Assets
-3.70
+35.93%
-5.77
-227.37%
4.53
+1506.83%
-0.32
Change In Payables And Accrued Expense
8.71
-49.27%
17.16
+485.17%
-4.46
-167.13%
6.64
Change In Accrued Expense
8.50
-19.31%
10.53
+368.22%
-3.93
-157.00%
6.89
Change In Payable
0.21
-96.86%
6.63
+1353.31%
-0.53
-110.76%
-0.25
Change In Account Payable
0.21
-96.86%
6.63
+1353.31%
-0.53
-110.76%
-0.25
Change In Other Working Capital
—
—
—
-33.19
Change In Other Current Assets
-0.29
-119.43%
1.47
+154.56%
-2.70
-2681.44%
-0.10
Change In Other Current Liabilities
-5.77
+7.93%
-6.27
+21.51%
-7.99
-7.75%
-7.42
Investing Cash Flow
218.69
+387.53%
-76.06
-284.87%
41.14
+123.96%
-171.70
Cash Flow From Continuing Investing Activities
218.69
+387.53%
-76.06
-284.87%
41.14
+123.96%
-171.70
Net PPE Purchase And Sale
-0.60
-514.29%
-0.10
-68.97%
-0.06
+94.55%
-1.06
Purchase Of PPE
-0.60
-514.29%
-0.10
-38.03%
-0.07
+93.33%
-1.06
Sale Of PPE
—
0.00
-100.00%
0.01
0.00
Capital Expenditure
-0.60
-514.29%
-0.10
-38.03%
-0.07
+93.33%
-1.06
Net Investment Purchase And Sale
219.29
+388.70%
-75.96
-284.37%
41.20
+124.14%
-170.63
Purchase Of Investment
-98.01
+66.57%
-293.16
-0.81%
-290.80
+3.27%
-300.63
Sale Of Investment
317.30
+46.09%
217.20
-34.58%
332.00
+155.38%
130.00
Financing Cash Flow
228.40
-35.30%
353.03
+244.17%
102.57
-47.35%
194.83
Cash Flow From Continuing Financing Activities
228.40
-35.30%
353.03
+244.17%
102.57
-47.35%
194.83
Net Issuance Payments Of Debt
49.14
0.00
0.00
0.00
Issuance Of Debt
74.66
0.00
—
0.00
Repayment Of Debt
-25.52
0.00
0.00
+100.00%
-0.97
Long Term Debt Issuance
74.66
0.00
—
0.00
Long Term Debt Payments
-25.52
0.00
0.00
+100.00%
-0.97
Net Long Term Debt Issuance
49.14
0.00
0.00
0.00
Net Common Stock Issuance
91.66
-71.75%
324.41
+232.02%
97.71
-49.97%
195.31
Proceeds From Stock Option Exercised
87.60
+204.81%
28.74
+491.09%
4.86
+888.21%
0.49
Net Other Financing Charges
—
-0.12
-4266.67%
0.00
+100.31%
-0.97
Changes In Cash
147.05
+93.43%
76.02
+5131.30%
-1.51
+98.62%
-109.56
Effect Of Exchange Rate Changes
-0.00
0.00
—
—
Beginning Cash Position
180.28
+72.92%
104.26
-1.43%
105.77
-50.88%
215.33
End Cash Position
327.33
+81.56%
180.28
+72.92%
104.26
-1.43%
105.77
Free Cash Flow
-300.64
-49.54%
-201.05
-38.37%
-145.30
-8.63%
-133.76
Interest Paid Supplemental Data
6.07
-8.33%
6.62
+3.41%
6.40
+46.36%
4.37
Amortization Of Securities
-3.99
+24.61%
-5.29
+14.94%
-6.22
-190.38%
-2.14
Common Stock Issuance
91.66
-71.75%
324.41
+232.02%
97.71
-49.97%
195.31
Issuance Of Capital Stock
91.66
-71.75%
324.41
+232.02%
97.71
-49.97%
195.31
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category